LLY vs RMD
By Alex · Tickerpine
Eli Lilly and Company vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | RMD |
|---|---|---|
| Price | $1,273.46 | $252.86 |
| Market cap | $1.14T | $35.56B |
| P/E ratio | 42.7 | 24.2 |
| ROE | 102.29% | 24.27% |
| Profit margin | 33.53% | 26.95% |
| Revenue growth | 47.70% | 8.60% |
| Dividend yield | 0.54% | 1.04% |
| Beta | 0.45 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs RMD in plain English
- LLY is the bigger company — about 31.9× the market cap of RMD.
- RMD is cheaper on earnings (P/E 24.2 vs 42.7).
- LLY earns a higher return on equity (102% vs 24%).
- LLY is growing revenue faster (48% vs 9%).
- RMD has the higher dividend yield (1.04% vs 0.54%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.